Parenta Pharmaceuticals

Parenta Pharmaceuticals was a specialty pharmaceutical company focused on the development and commercialization of generic injectable products. Based in the United States, the company maintained a portfolio of high-quality, cost-effective medications used primarily in hospital and clinical settings. The company specialized in niche generic products, including liquid and lyophilized formulations that required complex manufacturing processes. In 2005, Parenta was acquired by Hikma Pharmaceuticals for approximately $65 million to strengthen Hikma's presence in the U.S. market. Following the acquisition, its operations were integrated into Hikma's U.S. subsidiary, West-Ward Pharmaceuticals. The acquisition provided Hikma with a dedicated U.S. sales and marketing team and an established pipeline of generic injectable drugs.